American Oncology Network, Inc. Warrant
AONCW
AONCW was delisted on the 7th of June, 2024.
31 hedge funds and large institutions have $4.04M invested in American Oncology Network, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$205K |
| 2 |
Goldman Sachs
New York
|
+$152K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$120K |
| 4 |
SC
Sculptor Capital
New York
|
+$105K |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$99.8K |
Top Sellers
AONCW Hedge Fund Activity: Q2 2021 in Review
31 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Warrant (AONCW) for Q2 2021, worth a combined $4.04M.
Buyers outnumbered sellers: 31 funds opened new AONCW positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $205K.
- 31 institutional investors held American Oncology Network, Inc. Warrant (AONCW) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $4.04M of American Oncology Network, Inc. Warrant stock for Q2 2021.
- 31 funds opened new American Oncology Network, Inc. Warrant positions in Q2 2021 and 0 closed out, a net change of +31 holders.
- The largest American Oncology Network, Inc. Warrant buyer in Q2 2021 was Citadel Advisors, an estimated $205K added.
Based on aggregated 13F filings for Q2 2021.